Variant report
Variant | esv3353660 |
---|---|
Chromosome Location | chr3:84971162-84975660 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528177543 | chr3:84974400-84974401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546421861 | chr3:84974431-84974432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76076910 | chr3:84974438-84974439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570885515 | chr3:84974451-84974452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147015189 | chr3:84974483-84974484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs550560653 | chr3:84974516-84974517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553064653 | chr3:84974581-84974582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138079153 | chr3:84974588-84974589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536572125 | chr3:84974611-84974612 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548383350 | chr3:84974628-84974629 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566713590 | chr3:84974630-84974631 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs117250391 | chr3:84974678-84974679 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558733590 | chr3:84974746-84974747 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577276570 | chr3:84974780-84974781 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs28693686 | chr3:84974785-84974786 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs532842554 | chr3:84974825-84974826 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs60917138 | chr3:84974877-84974878 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs58662329 | chr3:84974886-84974887 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs575096104 | chr3:84974929-84974930 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560307628 | chr3:84974936-84974937 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78885292 | chr3:84974953-84974954 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546383509 | chr3:84974954-84974955 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555248633 | chr3:84974978-84974979 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs988121 | chr3:84974993-84974994 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368709418 | chr3:84975008-84975009 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs143664254 | chr3:84975096-84975097 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs374144383 | chr3:84975133-84975134 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs58564126 | chr3:84975152-84975153 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs548548907 | chr3:84975166-84975167 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112553809 | chr3:84975211-84975212 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566761775 | chr3:84975218-84975219 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs147477383 | chr3:84975228-84975229 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs138243396 | chr3:84975329-84975330 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570827287 | chr3:84975364-84975365 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs538362548 | chr3:84975371-84975372 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556119807 | chr3:84975398-84975399 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574535664 | chr3:84975407-84975408 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535746552 | chr3:84975410-84975411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190420172 | chr3:84975474-84975475 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572710679 | chr3:84975475-84975476 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs76104077 | chr3:84975488-84975489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546314927 | chr3:84975490-84975491 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs373991897 | chr3:84975545-84975546 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs564725187 | chr3:84975577-84975578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556436372 | chr3:84975586-84975587 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576842466 | chr3:84975587-84975588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs576311543 | chr3:84975596-84975597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181531427 | chr3:84975598-84975599 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs75708851 | chr3:84975619-84975620 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Autism | 22102821 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:84974400-84975200 | Enhancers | Brain Cingulate Gyrus | brain |
2 | chr3:84974600-84975400 | Active TSS | Brain Angular Gyrus | brain |
3 | chr3:84974800-84975200 | Active TSS | Brain Inferior Temporal Lobe | brain |
4 | chr3:84974800-84975400 | Active TSS | Brain Hippocampus Middle | brain |
5 | chr3:84975200-84975400 | Enhancers | Brain Inferior Temporal Lobe | brain |
6 | chr3:84975400-84976200 | Weak transcription | Brain Inferior Temporal Lobe | brain |
7 | chr3:84975400-84976400 | Enhancers | Brain Hippocampus Middle | brain |
8 | chr3:84975600-84976000 | Enhancers | Brain Angular Gyrus | brain |